The premenstrual syndrome and fibromyalgia - Similarities and common features

Clinical Reviews in Allergy and Immunology

Volumn 38, Issue 2-3, 2010, Pages 107-115

  Amital, Daniela ^a   Herskovitz, Calanit ^a   Fostick, Leah ^a   Silberman, Alysa ^a   Doron, Yariv ^a   Zohar, Joseph ^a   Itsekson, Alek ^a   Zolti, Matityahu ^a   Rubinow, Alan ^b   Amital, Howard ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

Anxiety; Depression; Fibromyalgia; Pain; Premenstrual dysphoric disorder

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE SEVERITY; DYSTHYMIA; FATIGUE; FEMALE; FIBROMYALGIA; GENERALIZED ANXIETY DISORDER; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INTERVIEW; PANIC; PHYSICAL DISABILITY; PHYSICAL EXAMINATION; PREMENSTRUAL SYNDROME; QUALITY OF LIFE; SHORT FORM 36; SLEEP; SYMPTOMATOLOGY; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; FEMALE; FIBROMYALGIA; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PAIN THRESHOLD; PREMENSTRUAL SYNDROME; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77953321338     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-009-8143-0     Document Type: Article

References (51)

1. Campbell EM, Peterkin D, O'Grady K, Sanson-Fisher R (1997) Premenstrual symptoms in general practice patients. Prevalence and treatment. J Reprod Med 42:637-646
2. Steiner M, Born L (2000) Diagnosis and treatment of premenstrual dysphoric disorder: an update. Int Clin Psychopharmacol 15 (Suppl 3):S5-S17 (Pubitemid 32041580)
3. Alonso C, Loevinger BL, Muller D, Coe CL (2004) Menstrual cycle influences on pain and emotion in women with fibromyalgia. J Psychosom Res 57:451-458
4. Straneva PA, Maixner W, Light KC, Pedersen CA, Costello NL, Girdler SS (2002) Menstrual cycle, beta-endorphins, and pain sensitivity in premenstrual dysphoric disorder. Health Psychol 21:358-367
5. Facchinetti F, Martignoni E, Petraglia F, Sances MG, Nappi G, Genazzani AR (1987) Premenstrual fall of plasma beta-endorphin in patients with premenstrual syndrome. Fertil Steril 47:570-573 (Pubitemid 17065617)
6. Giannini AJ, Martin DM, Turner CE (1990) Beta-endorphin decline in late luteal phase dysphoric disorder. Int J Psychiatry Med 20:279-284
7. Tulenheimo A, Laatikainen T, Salminen K (1987) Plasma beta-endorphin immunoreactivity in premenstrual tension. Br J Obstet Gynaecol 94:26-29
8. Giannini AJ, Melemis SM, Martin DM, Folts DJ (1994) Symptoms of premenstrual syndrome as a function of beta-endorphin: two subtypes. Prog Neuropsychopharmacol Biol Psychiatry 18:321-327
9. Taskin O, Gokdeniz R, Yalcinoglu A, Buhur A, Burak F, Atmaca R et al (1998) Placebo-controlled cross-over study of effects of tibolone on premenstrual symptoms and peripheral beta-endorphin concentrations in premenstrual syndrome. Hum Reprod 13:2402-2405
10. Yonkers KA (1997) Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders? J Clin Psychiatry 58(Suppl 3):62-67
11. Kim DR, Gyulai L, Freeman EW, Morrison MF, Baldassano C, Dube B (2004) Premenstrual dysphoric disorder and psychiatric co-morbidity. Arch Womens Ment Health 7:37-47
12. Olfson M, Fireman B, Weissman MM, Leon AC, Sheehan DV, Kathol RG et al (1997) Mental disorders and disability among patients in a primary care group practice. Am J Psychiatry 154:1734-1740
13. Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV) (1994) American Psychiatric Association, Washington D.C.
14. Thys-Jacobs S, Alvir JM, Fratarcangelo P (1995) Comparative analysis of three PMS assessment instruments - the identification of premenstrual syndrome with core symptoms. Psychopharmacol Bull 31:389-396
15. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22-33
16. Guy W (1976) Clinical global impressions ECDEU assessment manual for psychopharmacology. ECDEU: National institute of Health pp. 218-22
17. Sheehan DV (1983) The anxiety disease. Charles and Scribner, New York
18. Ware JE (1993) Measuring patients' views: the optimum outcome measure. BMJ 306:1429-1430
19. McHorney CA, Ware JE Jr, Raczek AE (1993) The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31:247-263
20. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS et al (1995) The development of a Clinician-Administered PTSD Scale. J Trauma Stress 8:75-90
21. Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728-733
22. Goldenberg DL, Mossey CJ, Schmid CH (1995) A model to assess severity and impact of fibromyalgia. J Rheumatol 22:2313-2318
23. Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137-145
24. Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE (1992) AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum 35:1-10
25. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160-172
26. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19-28
27. Dunkl PR, Taylor AG, McConnell GG, Alfano AP, Conaway MR (2000) Responsiveness of fibromyalgia clinical trial outcome measures. J Rheumatol 27:2683-2691
28. Freeman EW, Sondheimer SJ, Rickels K (1997) Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. Psychopharmacol Bull 33:303-309
29. Anderberg UM, Liu Z, Berglund L, Nyberg F (1998) Plasma levels on nociceptin in female fibromyalgia syndrome patients. Z Rheumatol 57(Suppl 2):77-80
30. Hellstrom B, Anderberg UM (2003) Pain perception across the menstrual cycle phases in women with chronic pain. Percept Mot Skills 96:201-211
31. Macfarlane TV, Blinkhorn A, Worthington HV, Davies RM, Macfarlane GJ (2002) Sex hormonal factors and chronic widespread pain: a population study among women. Rheumatology (Oxford) 41:454-457
32. Hapidou EG, Rollman GB (1998) Menstrual cycle modulation of tender points. Pain 77:151-161
33. Johns KR, Littlejohn GO (1999) The role of sex hormones in pain response. Pain 83:112-114
34. Ostensen M, Rugelsjoen A, Wigers SH (1997) The effect of reproductive events and alterations of sex hormone levels on the symptoms of fibromyalgia. Scand J Rheumatol 26:355-360
35. Freeman EW, Rickels K, Sondheimer SJ, Polansky M, Xiao S (2004) Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder. Am J Psychiatry 161:343-351
36. Halbreich U, Kahn LS (2003) Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline. Expert Opin Pharmacother 4:2065-2078
37. Bodo C, Rissman EF (2006) New roles for estrogen receptor beta in behavior and neuroendocrinology. Front Neuroendocrinol 27:217-232
38. Brandes JL (2006) The influence of estrogen on migraine: a systematic review. JAMA 295:1824-1830
39. Meseguer A, Puche C, Cabero A (2002) Sex steroid biosynthesis in white adipose tissue. Horm Metab Res 34:731-736
40. Stearns V (2006) Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms. Treat Endocrinol 5:83-87
41. Nagata H, Nozaki M, Nakano H (2005) Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies. J Obstet Gynaecol Res 31:107-114
42. Redmond G (1997) Mood disorders in the female patient. Int J Fertil Womens Med 42:67-72
43. Wittchen HU, Becker E, Lieb R, Krause P (2002) Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 32:119-132
44. Rojansky N, Halbreich U, Zander K, Barkai A, Goldstein S (1991) Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes. Gynecol Obstet Invest 31:146-152
45. Menkes DB, Coates DC, Fawcett JP (1994) Acute tryptophan depletion aggravates premenstrual syndrome. J Affect Disord 32:37-44
46. Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C et al (2006) Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt) 15:57-69
47. Dobie DJ, Maynard C, Kivlahan DR, Johnson KM, Simpson T, David AC et al (2006) Posttraumatic stress disorder screening status is associated with increased VA medical and surgical utilization in women. J Gen Intern Med 21(Suppl 3):S58-S64
48. Ablin JN, Shoenfeld Y, Buskila D (2006) Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle. J Autoimmun 27:145-152
49. Amital D, Fostick L, Polliack ML, Segev S, Zohar J, Rubinow A et al (2006) Posttraumatic stress disorder, tenderness, and fibromyalgia syndrome: are they different entities? J Psychosom Res 61:663-669
50. Buskila D, Atzeni F, Sarzi-Puttini P (2008) Etiology of fibromyalgia: the possible role of infection and vaccination. Autoimmun Rev 8:41-43
51. Cohen H, Neumann L, Haiman Y, Matar MA, Press J, Buskila D (2002) Prevalence of post-traumatic stress disorder in fibromyalgia patients: overlapping syndromes or post-traumatic fibromyalgia syndrome? Semin Arthritis Rheum 32:38-50